美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=EFAVIRENZ"
符合检索条件的记录共 53 条
共 3 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EFAVIRENZ 077916 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No No 2006/05/24 (TA) -- CIPLA LIMITED None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ 022096 001 NDA LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ TABLET; ORAL 150MG; 300MG; 600MG No No 2007/06/01 (TA) -- STRIDES ACROLAB None (Tentative Approval)
STAVUDINE; LAMIVUDINE; EFAVIRENZ 022097 001 NDA STAVUDINE; LAMIVUDINE; EFAVIRENZ TABLET; ORAL 40MG; 150MG; 600MG No No 2007/06/01 (TA) -- STRIDES ACROLAB None (Tentative Approval)
EFAVIRENZ 078958 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No No 2007/12/20 (TA) -- EMCURE PHARMA None (Tentative Approval)
EFAVIRENZ 078883 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No No 2008/04/25 (TA) -- MATRIX LABS None (Tentative Approval)
EFAVIRENZ 090155 001 ANDA EFAVIRENZ CAPSULE; ORAL 200MG No No 2009/08/03 (TA) -- CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090437 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG; 200MG; 300MG No No 2009/08/12 (TA) -- MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 022461 001 NDA EFAVIRENZ TABLET; ORAL 50MG No No 2009/11/24 (TA) -- MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 022461 002 NDA EFAVIRENZ TABLET; ORAL 100MG No No 2009/11/24 (TA) -- MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 022461 003 NDA EFAVIRENZ TABLET; ORAL 200MG No No 2009/11/24 (TA) -- MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ 200MG SCORED TABLETS 022420 001 NDA EFAVIRENZ TABLET; ORAL 200MG No No 2010/02/12 (TA) -- STRIDES ARCOLAB LTD None (Tentative Approval)
EFAVIRENZ 202042 001 ANDA EFAVIRENZ CAPSULE; ORAL 50MG No No 2012/01/19 (TA) -- MICRO LABS LTD None (Tentative Approval)
EFAVIRENZ 202042 002 ANDA EFAVIRENZ CAPSULE; ORAL 200MG No No 2012/01/19 (TA) -- MICRO LABS LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG No No 2012/02/27 (TA) -- CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 002 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG No No 2012/02/27 (TA) -- CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 003 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG No No 2012/02/27 (TA) -- CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ 202301 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No No 2012/06/20 (TA) -- MICRO LABS LTD None (Tentative Approval)
EFAVIRENZ 202990 001 ANDA EFAVIRENZ TABLET; ORAL 600MG No No 2012/06/25 (TA) -- PAR FORMULATIONS PRIVATE LTD None (Tentative Approval)
EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE 204568 001 NDA EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG No No 2013/12/30 (TA) -- CIPLA None (Tentative Approval)
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 205861 001 NDA EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG;300MG;300MG No No 2014/08/14 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database